Latest Cancer News

3-Year Survival Improved with Taflinar®/Mekinist® Combination in Advanced Melanoma (07-21-2016)
Patients with advanced melanoma who were treated with the combination consisting of Taflinar (dabrafenib) plus Mekinist (trametinib) had a significantly improved survival rate at 3 years compared to those... Continue Reading

Loxo Oncology Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-101 (07-19-2016)
Loxo Oncology, Inc. (LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced that the U.S. Food and Drug Administration... Continue Reading

FDA Places Hold on a Trial Evaluating Genetically Engineered Immune Cells for Cancer Treatment (07-18-2016)
The United States Food and Drug Administration (FDA) has placed a hold on a clinical trial, referred to as the ROCKET trial, due to side effects of the treatment that may be associated with 3 patient deaths. Chimeric... Continue Reading

More Cancer News

Locations

Youngstownthumb Youngstown
835 Southwestern Run
Youngstown, OH 44514
Phone: 330-318-1100
Fax: 330-318-1111
Warrenthumb Warren
1745 Niles Cortland
Road NE, Suite 5
Warren, OH 44484
Phone: 330-856-8600
Fax: 330-856-8686


 

Free Wi-Fi Now Available at Both Locations!